The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACADIA PHARMACEUTICALS IN | COM | 004225108 | 1,590,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | |||
ADICET BIO INC COM | COM | 007002108 | 1,379,995 | 154,708 | SH | SOLE | 154,708 | 0 | 0 | |||
ALBIREO PHARMA INC COM | COM | 01345P106 | 820,420 | 38,000 | SH | SOLE | 38,000 | 0 | 0 | |||
ALKERMES PLC SHS | SHS | G01767105 | 15,483,230 | 593,000 | SH | SOLE | 593,000 | 0 | 0 | |||
ALLOGENE THERAPEUTICS INC | COM | 019770106 | 314,000 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | |||
ALNYLAM PHARMACEUTICALS I | COM | 02043Q107 | 9,018,160 | 38,000 | SH | SOLE | 38,000 | 0 | 0 | |||
AMGEN INC COM | COM | 031162100 | 4,265,225 | 16,246 | SH | SOLE | 16,246 | 0 | 0 | |||
APELLIS PHARMACEUTICALS I | COM | 03753U106 | 1,638,256 | 31,700 | SH | SOLE | 31,700 | 0 | 0 | |||
ARVINAS INC COM | COM | 04335A105 | 580,550 | 17,000 | SH | SOLE | 17,000 | 0 | 0 | |||
ASCENDIS PHARMA A/S SPONS | Sponsored ADR | 04351P101 | 3,588,270 | 29,400 | SH | SOLE | 29,400 | 0 | 0 | |||
ASTRAZENECA PLC SPONSORED | SPONSORED ADR | 046353108 | 4,406,350 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | |||
AURINIA PHARMACEUTICALS I | COM | 05156V102 | 2,477,650 | 573,530 | SH | SOLE | 573,530 | 0 | 0 | |||
BEAM THERAPEUTICS INC COM | COM | 07373V105 | 919,085 | 23,500 | SH | SOLE | 23,500 | 0 | 0 | |||
BEIGENE LTD SPONSORED ADR | Sponsored ADR | 07725L102 | 3,452,116 | 15,700 | SH | SOLE | 15,700 | 0 | 0 | |||
BIOCRYST PHARMACEUTICALS | COM | 09058V103 | 653,790 | 57,000 | SH | SOLE | 57,000 | 0 | 0 | |||
BIOGEN INC COMMON STOCK | COM | 09062X103 | 5,923,520 | 21,400 | SH | SOLE | 21,400 | 0 | 0 | |||
BIOMARIN PHARMACEUTICAL I | COM | 09061G101 | 4,514,467 | 43,656 | SH | SOLE | 43,656 | 0 | 0 | |||
BLACK DIAMOND THERAPEUTIC | COM | 0920E3105 | 79,200 | 44,000 | SH | SOLE | 44,000 | 0 | 0 | |||
CARIBOU BIOSCIENCES INC C | COM | 142038108 | 1,619,562 | 257,892 | SH | SOLE | 257,892 | 0 | 0 | |||
CHINOOK THERAPEUTICS INC | COM | 16961L106 | 8,914,788 | 340,389 | SH | SOLE | 340,389 | 0 | 0 | |||
CONCERT PHARMACEUTICALS I | COM | 206022105 | 1,172,672 | 200,800 | SH | SOLE | 200,800 | 0 | 0 | |||
CRISPR THERAPEUTICS AG CO | NAMEN AKT | H17182108 | 1,390,230 | 34,200 | SH | SOLE | 34,200 | 0 | 0 | |||
DENALI THERAPEUTICS INC C | COM | 24823R105 | 1,056,020 | 38,000 | SH | SOLE | 38,000 | 0 | 0 | |||
DYNE THERAPEUTICS INC COM | COM | 26818M108 | 7,417,157 | 641,068 | SH | SOLE | 641,068 | 0 | 0 | |||
EXELIXIS INC COM | COM | 30161Q104 | 8,709,720 | 543,000 | SH | SOLE | 543,000 | 0 | 0 | |||
FATE THERAPEUTICS INC COM | COM | 31189P102 | 463,680 | 46,000 | SH | SOLE | 46,000 | 0 | 0 | |||
FULCRUM THERAPEUTICS INC | COM | 359616109 | 1,408,497 | 193,741 | SH | SOLE | 193,741 | 0 | 0 | |||
GILEAD SCIENCES INC COMMO | COM | 375558103 | 4,942,435 | 57,584 | SH | SOLE | 57,584 | 0 | 0 | |||
GUARDANT HEALTH INC COM | COM | 40131M109 | 2,024,165 | 74,500 | SH | SOLE | 74,500 | 0 | 0 | |||
Harmony Biosciences Holdi | COM | 413197104 | 14,560,725 | 264,500 | SH | SOLE | 264,500 | 0 | 0 | |||
HORIZON THERAPEUTICS PLC | SHS | G4617B105 | 35,828,179 | 314,973 | SH | SOLE | 314,973 | 0 | 0 | |||
HUTCHMED CHINA LIMITED SP | SPONSORED ADS | 44842L103 | 1,003,000 | 68,000 | SH | SOLE | 68,000 | 0 | 0 | |||
IDEAYA BIOSCIENCES INC CO | COM | 45166A102 | 1,980,530 | 109,000 | SH | SOLE | 109,000 | 0 | 0 | |||
ILLUMINA INC COM | COM | 452327109 | 9,396,720 | 46,500 | SH | SOLE | 46,500 | 0 | 0 | |||
I-MAB SPONSORED ADS | SPONSORED ADS | 44975P103 | 1,291,676 | 310,499 | SH | SOLE | 310,499 | 0 | 0 | |||
INCYTE CORP INC COM | COM | 45337C102 | 18,390,990 | 229,000 | SH | SOLE | 229,000 | 0 | 0 | |||
INSMED INC COM PAR $.01 | COM | 457669307 | 800,396 | 40,100 | SH | SOLE | 40,100 | 0 | 0 | |||
INTELLIA THERAPEUTICS INC | COM | 45826J105 | 836,640 | 24,000 | SH | SOLE | 24,000 | 0 | 0 | |||
INTRA-CELLULAR THERAPIES | COM | 46116X101 | 11,733,964 | 221,856 | SH | SOLE | 221,856 | 0 | 0 | |||
IOVANCE BIOTHERAPEUTICS I | COM | 462260100 | 357,280 | 56,000 | SH | SOLE | 56,000 | 0 | 0 | |||
IRONWOOD PHARMACEUTICALS | COM | 46333X108 | 743,400 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | |||
JAZZ PHARMACEUTICALS PLC | SHS USD | G50871105 | 2,739,444 | 17,200 | SH | SOLE | 17,200 | 0 | 0 | |||
KRYSTAL BIOTECH INC COM | COM | 501147102 | 3,558,150 | 45,000 | SH | SOLE | 45,000 | 0 | 0 | |||
Legend Biotech Corp | SPONSORED ADS | 52490G102 | 1,894,300 | 38,000 | SH | SOLE | 38,000 | 0 | 0 | |||
MIRATI THERAPEUTICS INC C | COM | 60468T105 | 11,055,640 | 244,000 | SH | SOLE | 244,000 | 0 | 0 | |||
MIRUM PHARMACEUTICALS INC | COM | 604749101 | 1,312,875 | 67,500 | SH | SOLE | 67,500 | 0 | 0 | |||
NOVAVAX INC | COM | 670002401 | 1,360,775 | 132,500 | SH | SOLE | 132,500 | 0 | 0 | |||
Novocure Ltd | ORD SHS | G6674U108 | 2,344,000 | 32,000 | SH | SOLE | 32,000 | 0 | 0 | |||
PTC THERAPEUTICS INC COM | COM | 69366J200 | 5,493,600 | 144,000 | SH | SOLE | 144,000 | 0 | 0 | |||
REGENERON PHARMACEUTICALS | COM | 75886F107 | 8,080,128 | 11,200 | SH | SOLE | 11,200 | 0 | 0 | |||
RELMADA THERAPEUTICS INC | COM | 75955J402 | 34,900 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | |||
REVANCE THERAPEUTICS INC | COM | 761330109 | 2,214,000 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | |||
ROCKET PHARMACEUTICALS IN | COM | 77313F106 | 1,231,020 | 63,000 | SH | SOLE | 63,000 | 0 | 0 | |||
SANOFI | SPONSORED ADR | 80105N105 | 6,942,530 | 143,500 | SH | SOLE | 143,500 | 0 | 0 | |||
SEAGEN INC COM | COM | 81181C104 | 21,356,700 | 166,200 | SH | SOLE | 166,200 | 0 | 0 | |||
SUPERNUS PHARMACEUTICALS | COM | 868459108 | 13,671,775 | 383,500 | SH | SOLE | 383,500 | 0 | 0 | |||
TRAVERE THERAPEUTICS INC | COM | 89422G107 | 7,963,189 | 379,019 | SH | SOLE | 379,019 | 0 | 0 | |||
ULTRAGENYX PHARMACEUTICAL | COM | 90400D108 | 8,060,348 | 174,052 | SH | SOLE | 174,052 | 0 | 0 | |||
UNIQURE N.V. COM EUR0.05 | SHS | N90064101 | 14,297,160 | 631,500 | SH | SOLE | 631,500 | 0 | 0 | |||
UNITED THERAPEUTICS CORP | COM | 91307C102 | 4,171,200 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | |||
VERA THERAPEUTICS | CL A | 92337R101 | 5,428,260 | 281,257 | SH | SOLE | 281,257 | 0 | 0 | |||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 1,003,425 | 25,500 | SH | SOLE | 25,500 | 0 | 0 | |||
ZAI LAB LTD ADR | ADR | 98887Q104 | 2,423,221 | 78,958 | SH | SOLE | 78,958 | 0 | 0 |